Sandler Capital Management Takes Position in Danaher Corporation $DHR

Key Points

• Sandler Capital Management acquired 4,981 shares of Danaher Corporation (NYSE:DHR), valued at approximately $1,021,000, during the first quarter of 2023.
• Danaher reported $1.80 earnings per share for the latest quarter, surpassing analysts' estimates of $1.64, along with a revenue increase of 3.4% year-over-year.
• Seventeen research analysts have rated Danaher with a Buy rating, indicating strong market confidence, and the average target price is set at $246.35.

Sandler Capital Management purchased a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 4,981 shares of the conglomerate's stock, valued at approximately $1,021,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Parkman Healthcare Partners LLC acquired a new stake in shares of Danaher during the 1st quarter worth approximately $12,966,000. Parkwood LLC grew its holdings in Danaher by 113.8% in the 1st quarter. Parkwood LLC now owns 98,036 shares of the conglomerate's stock worth $20,097,000 after buying an additional 52,180 shares in the last quarter. PharVision Advisers LLC bought a new position in Danaher in the 1st quarter worth approximately $284,000. Nissay Asset Management Corp Japan ADV grew its holdings in Danaher by 1.0% in the 1st quarter. Nissay Asset Management Corp Japan ADV now owns 80,806 shares of the conglomerate's stock worth $16,565,000 after buying an additional 816 shares in the last quarter. Finally, Napean Trading & Investment Co Singapore PTE Ltd grew its holdings in Danaher by 16.2% in the 1st quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 64,498 shares of the conglomerate's stock worth $13,222,000 after buying an additional 9,001 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Royal Bank Of Canada set a $241.00 price objective on Danaher in a report on Tuesday, September 2nd. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research note on Friday, July 11th. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Guggenheim reaffirmed a "buy" rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Evercore ISI decreased their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $246.35.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 11.20% of the stock is owned by insiders.

Danaher Price Performance

Shares of NYSE:DHR traded down $4.39 on Tuesday, reaching $194.24. 3,344,891 shares of the company traded hands, compared to its average volume of 2,899,976. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The company's 50 day moving average is $201.82 and its 200-day moving average is $199.20. The stock has a market capitalization of $139.09 billion, a PE ratio of 41.33, a P/E/G ratio of 2.77 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the prior year, the firm earned $1.72 EPS. The company's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. Danaher's payout ratio is currently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.